Anticoagulation for people receiving long-term haemodialysis
CONCLUSIONS: Anticoagulant strategies, including UFH and LMWH, have uncertain comparative risks on extracorporeal circuit thrombosis, while major bleeding and minor bleeding were not adequately reported. Regional citrate may decrease minor bleeding, but the effects on major bleeding and extracorporeal circuit thrombosis were not reported. Evidence supporting clinical decision-making for different forms of anticoagulant strategies for HD is of low and very low certainty, as available studies have not been designed to measure treatment effects on important clinical outcomes.PMID:38189593 | PMC:PMC10772979 | DOI:10.1002/14651858.CD011858.pub2
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Patrizia Natale Suetonia C Palmer Marinella Ruospo Henrietta Longmuir Benjamin Dodds Ritam Prasad Tracey J Batt Matthew D Jose Giovanni Fm Strippoli Source Type: research
More News: Bleeding | Blood Transusion | Child Development | Children | Clinical Trials | Conferences | Databases & Libraries | Dialysis | General Medicine | Heart Attack | Hemodiafiltration | Hemodialysis | Kidney Transplant | Kidney Transplantation | PET Scan | Stroke | Study | Thrombosis | Transplant Surgery | Transplants | Urology & Nephrology